- Home
- ADCT vs SB Comparison
ADCT vs SB Comparison
Compare ADCT & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- SB
- Stock Information
- Founded
- ADCT 2011
- SB 2007
- Country
- ADCT Switzerland
- SB Monaco
- Employees
- ADCT N/A
- SB N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- SB Marine Transportation
- Sector
- ADCT Health Care
- SB Consumer Discretionary
- Exchange
- ADCT Nasdaq
- SB Nasdaq
- Market Cap
- ADCT 398.2M
- SB 434.9M
- IPO Year
- ADCT 2020
- SB 2008
- Fundamental
- Price
- ADCT $3.25
- SB $4.57
- Analyst Decision
- ADCT Strong Buy
- SB Strong Buy
- Analyst Count
- ADCT 6
- SB 1
- Target Price
- ADCT $7.80
- SB $5.00
- AVG Volume (30 Days)
- ADCT 545.2K
- SB 331.6K
- Earning Date
- ADCT 11-06-2025
- SB 11-12-2025
- Dividend Yield
- ADCT N/A
- SB 4.39%
- EPS Growth
- ADCT N/A
- SB N/A
- EPS
- ADCT N/A
- SB 0.43
- Revenue
- ADCT $77,246,000.00
- SB $277,509,000.00
- Revenue This Year
- ADCT $13.10
- SB N/A
- Revenue Next Year
- ADCT $6.23
- SB $14.56
- P/E Ratio
- ADCT N/A
- SB $10.56
- Revenue Growth
- ADCT 15.73
- SB N/A
- 52 Week Low
- ADCT $1.05
- SB $3.02
- 52 Week High
- ADCT $3.97
- SB $5.24
- Technical
- Relative Strength Index (RSI)
- ADCT 51.93
- SB 68.39
- Support Level
- ADCT $3.15
- SB $4.55
- Resistance Level
- ADCT $3.38
- SB $4.63
- Average True Range (ATR)
- ADCT 0.18
- SB 0.09
- MACD
- ADCT -0.02
- SB 0.01
- Stochastic Oscillator
- ADCT 38.53
- SB 83.33
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.